Centre for Biostatistics and Genetic Epidemiology, Department of Health Sciences, 2nd Floor Adrian Building, University of Leicester, University Road, Leicester LE1 7RH, UK.
Cancer Epidemiol. 2011 Dec;35(6):526-33. doi: 10.1016/j.canep.2011.04.003. Epub 2011 May 24.
Survival from breast cancer is lower in the UK than in some other European countries. We compared survival in England and Norway by age and time from diagnosis.
We included 303,648 English and 24,919 Norwegian cases of breast cancer diagnosed 1996-2004 using flexible parametric relative survival models, enabling improved quantification of differences in survival. Crude probabilities were estimated to partition the probability of death due to all causes into that due to cancer and other causes and to estimate the number of "avoidable" deaths.
England had lower relative survival for all ages with the difference increasing with age. Much of the difference was due to higher excess mortality in England in the first few months after diagnosis. Older patients had a higher proportion of deaths due to other causes. At 5 years post diagnosis, a woman aged 85 in England had probabilities of 0.35 of dying of cancer and 0.32 of dying of other causes, whilst in Norway they were 0.26 and 0.35. By eight years the number of "avoidable" all-cause deaths in England was 1020 with the number of "avoidable" breast cancer related deaths 1488.
Lower breast cancer survival in England is mainly due to higher mortality in the first year after diagnosis. Crude probabilities aid our understanding of the impact of disease on individual patients and help assess different treatment options.
英国的乳腺癌生存率低于一些其他欧洲国家。我们比较了英格兰和挪威的生存率,按年龄和诊断后时间进行比较。
我们纳入了 1996-2004 年间诊断的 303648 例英国和 24919 例挪威乳腺癌病例,使用灵活的参数相对生存模型进行分析,从而能够更好地量化生存差异。通过粗概率来划分全因死亡率,将癌症和其他原因导致的死亡率分开,并估计“可避免”的死亡人数。
所有年龄段的英格兰相对生存率都较低,且这种差异随着年龄的增长而增加。差异的大部分原因是诊断后最初几个月英格兰的超额死亡率较高。老年患者的其他原因死亡率较高。在诊断后 5 年,年龄为 85 岁的英国女性死于癌症的概率为 0.35,死于其他原因的概率为 0.32,而在挪威这两个概率分别为 0.26 和 0.35。到 8 年时,英国的全因“可避免”死亡人数为 1020 人,乳腺癌相关的“可避免”死亡人数为 1488 人。
英国乳腺癌生存率较低主要是由于诊断后第一年的死亡率较高。粗概率有助于我们了解疾病对个体患者的影响,并帮助评估不同的治疗方案。